Josh Hexter joined Oramed (NASDAQ: ORMP) as Chief Operating & Business Officer in the fall of 2019. He brings to Oramed more than 20 years of prominent leadership, business development, operations know-how and management in biotechnology and medical devices.
Prior to joining Oramed, Josh was the Chief Business Officer at BrainsWay (NASDAQ: BWAY). Prior to BrainsWay Josh was the Chief Operating Officer at Oramed (NASDAQ: ORMP) and prior to that he was the Executive Director of Corporate Licensing at BioLineRx (NASDAQ: BLRX). Before joining BioLineRx, Josh worked in private equity and venture capital and served as CEO of a VC-backed startup.